Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trio topical agent versus urea for keratosis pilaris of the outer arms
TCTR20250401001Phase 2Completed
- Sponsor
- Ramathibodi Hospital
- Start
- Jul 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Salvax, Licochalcone A, urea in keratosis pilaris (KP), sponsored by Ramathibodi Hospital. Started Jul 2023; status: completed.
02
Drugs
SalvaxLicochalcone Aurea
03
Conditions
keratosis pilaris (KP)
Beyond the preview
Go deeper on TCTR20250401001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20250401001.